Your browser is no longer supported. Please, upgrade your browser.
Settings
ACAD ACADIA Pharmaceuticals Inc. daily Stock Chart
ACAD [NASD]
ACADIA Pharmaceuticals Inc.
Index- P/E- EPS (ttm)-1.15 Insider Own25.84% Shs Outstand100.30M Perf Week1.32%
Market Cap4.83B Forward P/E- EPS next Y-0.93 Insider Trans-0.23% Shs Float100.01M Perf Month15.59%
Income-115.00M PEG- EPS next Q-0.33 Inst Own97.60% Short Float13.68% Perf Quarter31.81%
Sales0.09M P/S51419.75 EPS this Y-115.90% Inst Trans0.07% Short Ratio13.13 Perf Half Y54.90%
Book/sh2.85 P/B16.91 EPS next Y31.60% ROA-40.00% Target Price43.78 Perf Year133.71%
Cash/sh2.97 P/C16.23 EPS next 5Y20.00% ROE-41.70% 52W Range19.67 - 51.99 Perf YTD51.78%
Dividend- P/FCF- EPS past 5Y4.60% ROI-30.10% 52W High-7.31% Beta3.12
Dividend %- Quick Ratio18.00 Sales past 5Y-56.50% Gross Margin- 52W Low144.99% ATR1.80
Employees119 Current Ratio18.00 Sales Q/Q-86.70% Oper. Margin- RSI (14)57.14 Volatility3.97% 4.08%
OptionableYes Debt/Eq0.00 EPS Q/Q-110.50% Profit Margin- Rel Volume0.60 Prev Close48.81
ShortableYes LT Debt/Eq0.00 EarningsAug 06 AMC Payout- Avg Volume1.04M Price48.19
Recom1.70 SMA202.38% SMA5011.00% SMA20035.14% Volume628,533 Change-1.27%
Apr-16-15Initiated Leerink Partners Outperform $48
Mar-12-15Reiterated Needham Buy $40 → $38
Feb-24-15Initiated H.C. Wainwright Buy $50
Feb-06-15Resumed ROTH Capital Buy $42
Dec-22-14Reiterated Needham Buy $26 → $40
Aug-07-13Reiterated Needham Buy $16 → $26
Aug-07-13Reiterated Ladenburg Thalmann Buy $15 → $24
Aug-07-13Downgrade MLV & Co Buy → Hold $18 → $20
Apr-11-13Reiterated Needham Buy $9 → $16
Apr-11-13Reiterated MLV & Co Buy $12.50 → $18
Apr-11-13Reiterated Ladenburg Thalmann Buy $9 → $15
Mar-13-13Reiterated Ladenburg Thalmann Buy $8 → $9
Nov-28-12Reiterated MLV & Co Buy $4.50 → $8.50
Nov-27-12Upgrade Needham Hold → Buy $9
Nov-27-12Reiterated Ladenburg Thalmann Buy $8
Apr-30-12Initiated Ladenburg Thalmann Buy
Sep-01-09Downgrade Citigroup Hold → Sell
May-05-09Upgrade JMP Securities Mkt Perform → Mkt Outperform $7
Aug-06-08Downgrade JMP Securities Mkt Outperform → Mkt Perform
Jul-08-08Upgrade Banc of America Sec Sell → Neutral
Jul-30-15 09:00AM  ACADIA Pharmaceuticals to Announce Second Quarter Financial Results on August 6, 2015 Business Wire
Jul-13-15 12:28PM  Notable option activity in equities
Jun-26-15 03:31AM  Edited Transcript of ACAD presentation 24-Jun-15 3:00pm GMT
Jun-19-15 04:43PM  ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a
Jun-17-15 09:00AM  ACADIA Pharmaceuticals to Present at the JMP Securities Life Sciences Conference on June 24, 2015 Business Wire
Jun-16-15 09:00AM  ACADIA Pharmaceuticals Presents Integrated Data from Its Phase III Program with NUPLAZID (Pimavanserin) for Parkinsons Disease Psychosis at the 19th International Congress of Parkinsons Disease and Movement Disorders Business Wire
May-26-15 09:00AM  ACADIA Pharmaceuticals to Present at the Jefferies 2015 Healthcare Conference on June 2, 2015 Business Wire
May-20-15 01:04PM  ACADIA PHARMACEUTICALS INC Financials
May-18-15 01:38PM  Viking Global Liked AIG, Google, Actavis, Illumina And Cheniere Energy Last Quarter
May-09-15 08:09PM  10-Q for ACADIA Pharmaceuticals, Inc. at Company Spotlight
02:00PM  ACADIA INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Acadia Pharmaceuticals, Inc. (ACAD) to Contact the Firm Before the Imminent Lead Plaintiff Deadline GlobeNewswire
May-08-15 02:52PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in ACADIA Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline - ACAD PR Newswire
01:24PM  UPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Shareholders of Acadia Pharmaceuticals Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of May 12, 2015 -- ACAD GlobeNewswire
May-07-15 06:24PM  Acadia reports 1Q loss
05:00PM  ACADIA Pharmaceuticals Inc Earnings Call scheduled for 5:00 pm ET today
04:06PM  ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an
04:01PM  ACADIA Pharmaceuticals Reports First Quarter 2015 Financial Results Business Wire
07:07AM  Q1 2015 ACADIA Pharmaceuticals Inc Earnings Release - After Market Close
May-06-15 01:14PM  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in ACADIA Pharmaceuticals Inc. to Contact Brower Piven Before the Lead Plaintiff Deadline in Class Action Lawsuit ACAD GlobeNewswire
09:49AM  ACADIA Pharmaceuticals to Present at the Bank of America Merrill Lynch 2015 Health Care Conference on May 13, 2015 at noodls
09:00AM  ACADIA Pharmaceuticals to Present at the Bank of America Merrill Lynch 2015 Health Care Conference on May 13, 2015 Business Wire
May-04-15 07:30PM  DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders Of ACADIA Pharmaceuticals Inc. Of Upcoming Deadline Business Wire
Apr-30-15 09:36AM  ACADIA Pharmaceuticals to Announce First Quarter Financial Results on May 7, 2015 at noodls
09:00AM  ACADIA Pharmaceuticals to Announce First Quarter Financial Results on May 7, 2015 Business Wire
Apr-29-15 03:56PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Acadia Pharmaceuticals Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of May 12, 2015 - ACAD PR Newswire
12:58PM  ALERT: Morgan & Morgan Reminds Investors That a Class Action Lawsuit Has Been Filed Against ACADIA Pharmaceuticals Inc. and of the LP Deadline of May 12, 2015 -- ACAD GlobeNewswire
Apr-24-15 05:37PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in ACADIA Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline -- ACAD GlobeNewswire
Apr-21-15 10:43AM  SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notify Investors of Class Action Involving Acadia Pharmaceuticals Inc. and a Lead Plaintiff Deadline of May 12, 2015 Business Wire
Apr-20-15 03:54PM  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In ACADIA Pharmaceuticals Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit Business Wire
03:10PM  Lifshitz & Miller Law Firm Announces Investigation of Acadia Pharmaceuticals Inc., Akorn, Inc., Dover Saddlery, Inc., Excel Trust, Inc., Informatica Corporation, Inogen, Inc. and Zep, Inc. PR Newswire
Apr-16-15 09:39AM  Acadia Will Outperform, Worth $48/Share Says Leerink
06:30AM  Coverage initiated on ACADIA Pharmaceuticals by Leerink Partners
Apr-15-15 01:38PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Acadia Pharmaceuticals Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of May 12, 2015 Business Wire
Apr-14-15 07:33PM  Cramer Remix: This company's worth double at CNBC
Apr-07-15 09:20AM  ACADIA Pharmaceuticals to Present at the 14th Annual Needham Healthcare Conference on April 14, 2015 at noodls
09:00AM  ACADIA Pharmaceuticals to Present at the 14th Annual Needham Healthcare Conference on April 14, 2015 Business Wire
Apr-06-15 07:58PM  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in ACADIA Pharmaceuticals Inc. to Contact Brower Piven Before the Lead Plaintiff Deadline in Class Action Lawsuit ACAD GlobeNewswire
12:07PM  Cohen Milstein Sellers & Toll PLLC Announces the Investigation of ACADIA Pharmaceuticals, Inc. GlobeNewswire
10:56AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Acadia Pharmaceuticals Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of May 12, 2015 -- ACAD GlobeNewswire
Mar-30-15 04:11PM  ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Changes in Registrant's Certifying Accountant
Mar-27-15 09:00PM  IMPORTANT ANNOUNCEMENT: Wolf Haldenstein Adler Freeman & Herz LLP Announces That a Federal Securities Class Action Has Been Filed Against ACADIA Pharmaceuticals Inc. in the United States District Court for the Southern District of Californi GlobeNewswire +5.24%
Mar-26-15 08:28AM  ACADIA Pharmaceuticals Appoints Daniel Soland to Board of Directors at noodls
08:00AM  ACADIA Pharmaceuticals Appoints Daniel Soland to Board of Directors Business Wire
06:05AM  ACADIA PHARMACEUTICALS INC Files SEC form 8-K/A, Change in Directors or Principal Officers
Mar-25-15 05:04PM  ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Change in Directors or -7.28%
03:45PM  Superconductor Technologies, Inc. (SCON), Pfizer Inc. (PFE), ACADIA Pharmaceuticals Inc. (ACAD): Sabby Capitals Latest Moves in Healthcare Sector at Insider Monkey
01:07PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Acadia Pharmaceuticals Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of May 12, 2015 - ACAD Marketwired
12:32PM  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In ACADIA Pharmaceuticals Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit Business Wire
Mar-24-15 07:30PM  Gainey McKenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against ACADIA Pharmaceuticals, Inc. -- ACAD GlobeNewswire
Mar-23-15 08:30AM  Hagens Berman Alerts ACADIA Pharmaceuticals, Inc. (NASDAQ:ACAD) Investors With Over $100,000 in Losses of May 12th Lead Plaintiff Deadline GlobeNewswire
Mar-20-15 10:00PM  ACADIA SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. Business Wire
Mar-19-15 09:30AM  The Zacks Analyst Blog Highlights: Amgen, Regeneron, Nektar, ACADIA and Pharmacyclics - Press Releases
Mar-18-15 12:44PM  INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $50,000 Investing in Acadia Pharmaceuticals, Inc. (ACAD) to Contact the Firm Marketwired
10:49AM  Biotech Stock Roundup: Amgen & Regeneron Shine at ACC, Nektar Drug Disappoints - Analyst Blog
10:00AM  ACADIA Pharmaceuticals Inc. Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor Investigate Possible Breaches of Fiduciary Duty by Officers and Directors Business Wire
09:45AM  Deadline in Lawsuit for Investors in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Shares Announced by Shareholders Foundation GlobeNewswire
Mar-17-15 08:45PM  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in ACADIA Pharmaceuticals Inc. to Contact Brower Piven Before the Lead Plaintiff Deadline in Class Action Lawsuit -- ACAD GlobeNewswire
06:38PM  Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against ACADIA Pharmaceuticals Inc. PR Newswire
10:26AM  Morgan & Morgan Announces That a Class Action Lawsuit Was Filed Against ACADIA Pharmaceuticals Inc. -- ACAD GlobeNewswire
Mar-16-15 10:00PM  ACADIA SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. -- ACAD GlobeNewswire
07:18PM  SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against ACADIA Pharmaceuticals Inc. and Certain Officers -- ACAD GlobeNewswire
02:15PM  INVESTOR ALERT: Investigation of ACADIA Pharmaceuticals Inc. Announced by Glancy Binkow & Goldberg LLP Business Wire
12:28PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of ACADIA PHARMACEUTICALS INC. of PENDENCY OF CLASS ACTION Lawsuit and a Lead Plaintiff DEADLINE of May 12, 2015 -- ACAD GlobeNewswire
10:01AM  Acadia Pharmaceuticals Inc. Investors Encouraged to Contact Securities Law Firm about Investigation into Allegations of Corporate Wrongdoing PR Newswire
09:11AM  Law Offices of Marc S. Henzel Announces Securities Class Action Periods PR Newswire
Mar-13-15 10:00PM  Robbins Geller Rudman & Dowd LLP Files Class Action Suit against ACADIA Pharmaceuticals Inc. Business Wire
08:48PM  Lightning Round: Time to take profits on this at CNBC
08:14PM  Robbins Arroyo LLP Is Investigating the Officers and Directors of ACADIA Pharmaceuticals Inc. (ACAD) on Behalf of Shareholders PR Newswire
04:25PM  ACADIA Down on Nuplazid NDA Delay and CEO Resignation - Analyst Blog
04:00PM  INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Acadia Pharmaceuticals, Inc. (ACAD) To Contact The Firm PR Newswire
01:24PM  Nasdaq stocks posting largest percentage decreases
08:50AM  ACADIA Pharmaceuticals (ACAD) Crumbles: Stock Falls by 22.2% - Tale of the Tape
Mar-12-15 08:10PM  Harwood Feffer LLP Announces Investigation of Acadia Pharmaceuticals Inc. PR Newswire -22.21%
06:04PM  Most active Nasdaq-traded stocks
05:03PM  Citigroup and Intel are big market movers
04:15PM  CFO Moves: Dollar General, ACADIA Pharmaceuticals, Endologix at The Wall Street Journal
03:14PM  ACAD SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Violations of Federal Securities Laws by Acadia Pharmaceuticals Inc. Business Wire
01:56PM  Acadia Pharma Tumbles On Drug Delay, CEO Departure at Investor's Business Daily
01:08PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ACADIA Pharmaceuticals Inc. - ACAD PR Newswire
12:00PM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Acadia Pharmaceuticals Inc. PR Newswire
11:25AM  U.S. stocks rebound as rate-hike fear, dollars surge ease at MarketWatch
11:12AM  US stocks lifted by financials as dollar dips
11:11AM  Acadia Pharmaceuticals (ACAD) Stock Tanks Today on Delayed Regulatory Application at TheStreet
10:40AM  US open: Dow gains over 170 points as dollar's rally slows down
09:05AM  Shake Shack shakedown; Lumber Liquidators repairs rep; Krispy Kreme gets dunked
08:04AM  Early movers: SHAK, BOX, DG, HPQ, UTX, LL & more at CNBC
08:02AM  Bulls push back as dollar rally fades; Retail sales fall again; Mattel's "creepy" Barbie
Mar-11-15 08:52PM  US pre-open: Futures point to mixed open as dollar's surge loses momentum Sharecast
04:39PM  Acadia Drug Is Delayed Again as CEO Announces Retirement at TheStreet
04:35PM  Acadia shares drop 22% on drug delay, CEO departure at MarketWatch
04:28PM  Acadia Pharma tanks on sudden CEO retirement at CNBC
04:24PM  Acadia delays U.S. application to market lead drug, CEO retires Reuters
04:02PM  ACADIA Pharmaceuticals Announces Retirement of Uli Hacksell, Ph.D., Chief Executive Officer Business Wire
04:01PM  ACADIA Pharmaceuticals Updates Planned Timing of NUPLAZIDTM NDA Submission Business Wire
01:38PM  Nasdaq stocks posting largest percentage increases AP
01:01PM  Acadia's Absence Makes Hearts Grow Fonder at The Wall Street Journal
Mar-10-15 07:00PM  ACADIA Pharmaceuticals Inc. (ACAD), Pfizer Inc. (PFE): Sabby Management Rewarded for Its Healthcare Picks at Insider Monkey +17.85%
05:03PM  Stocks End At Session Lows; Habit Down After Hours at Investor's Business Daily
02:51PM  Acadia Rises as Canceled Events Cause Deal Speculation at Bloomberg
Feb-27-15 07:37PM  Cramer Remix: Look for this from Warren Buffett at CNBC
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in neurological and related central nervous system disorders. Its lead product candidate is NUPLAZID, which completed the Phase III pivotal trials for the treatment of Parkinson's disease psychosis; is in Phase II study for Alzheimer's disease psychosis; and has completed Phase II trial for the treatment of schizophrenia. It also has clinical-stage programs for chronic pain and glaucoma in collaboration with Allergan, Inc. ACADIA Pharmaceuticals Inc. was founded in 1993 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Iversen Leslie LDirectorJun 01Option Exercise8.8514,127125,02427,627Jun 03 04:04 PM
Hacksell UliCEOFeb 17Option Exercise1.5530,00046,50030,000Feb 19 05:58 PM
Rasmussen TorstenDirectorFeb 17Option Exercise4.9019,84797,20128,347Feb 19 06:00 PM
Hacksell UliCEOFeb 17Sale34.3030,0001,028,868115,549Feb 19 05:58 PM
Rasmussen TorstenDirectorFeb 17Sale35.0519,847695,5448,500Feb 19 06:00 PM
Brege LauraDirectorFeb 11Option Exercise1.7510,00017,50010,000Feb 13 05:57 PM
Brege LauraDirectorFeb 11Sale33.6310,000336,3490Feb 13 05:57 PM
BORER MICHAEL TDirectorJan 15Option Exercise11.8227,973330,59227,973Jan 16 05:52 PM
BORER MICHAEL TDirectorJan 15Sale33.0227,973923,7660Jan 16 05:52 PM
Hacksell UliCEOJan 14Option Exercise2.0030,00060,00030,000Jan 16 05:51 PM
Hacksell UliCEOJan 14Sale33.9830,0001,019,430115,549Jan 16 05:51 PM
GRAY MARY ANNDirectorJan 13Option Exercise11.004,25046,7504,250Jan 15 06:02 PM
Rasmussen TorstenDirectorJan 13Option Exercise11.0611,905131,66720,405Jan 15 06:03 PM
Rasmussen TorstenDirectorJan 13Sale35.0011,905416,6768,500Jan 15 06:03 PM
GRAY MARY ANNDirectorJan 13Sale35.004,250148,7500Jan 15 06:02 PM
Hacksell UliCEODec 15Option Exercise2.0030,00060,00030,000Dec 17 05:37 PM
GRAY MARY ANNDirectorDec 15Option Exercise9.4512,250115,78012,250Dec 17 05:38 PM
GRAY MARY ANNDirectorDec 15Sale31.7412,250388,8150Dec 17 05:38 PM
Hacksell UliCEODec 15Sale31.0030,000929,916115,549Dec 17 05:37 PM
Baity GlennEVP AND GCDec 09Option Exercise1.558,00012,40062,423Dec 10 06:53 PM
Mills RogerEVP, DEVELOPMENT AND CMONov 26Option Exercise0.0025,000043,550Nov 26 06:29 PM
BORER MICHAEL TDirectorNov 26Option Exercise11.0015,000165,00015,000Nov 26 06:29 PM
BORER MICHAEL TDirectorNov 26Sale30.0515,000450,7650Nov 26 06:29 PM
Mills RogerEVP, DEVELOPMENT AND CMONov 26Sale30.0925,000752,26518,550Nov 26 06:29 PM
Hacksell UliCEONov 24Option Exercise2.0030,00060,00030,000Nov 26 06:27 PM
Hacksell UliCEONov 24Sale29.2830,000878,397115,549Nov 26 06:27 PM
Wells William McDowallDirectorNov 21Option Exercise1.365,8107,9025,810Nov 21 07:48 PM
Wells William McDowallDirectorNov 21Sale29.005,810168,4900Nov 21 07:48 PM
Hacksell UliCEOOct 08Option Exercise2.0030,00060,00030,000Oct 10 05:30 PM
Hacksell UliCEOOct 08Sale24.1530,000724,530115,549Oct 10 05:30 PM
Brege LauraDirectorSep 15Option Exercise1.7510,00017,50010,000Sep 16 06:05 PM
Brege LauraDirectorSep 15Sale28.0710,000280,6690Sep 16 06:05 PM
Wells William McDowallDirectorSep 12Option Exercise1.369,19012,4989,190Sep 16 06:04 PM
Wells William McDowallDirectorSep 12Sale29.159,190267,8730Sep 16 06:04 PM
Hacksell UliCEOSep 10Option Exercise2.0030,00060,00030,000Sep 12 05:56 PM
Hacksell UliCEOSep 10Sale27.3630,000820,821115,549Sep 12 05:56 PM
Wells William McDowallDirectorSep 02Option Exercise1.3630,00040,80030,000Sep 04 06:06 PM
KAPLAN LESTER J PH DDirectorSep 02Option Exercise1.3057,69275,00066,192Sep 04 06:11 PM
KAPLAN LESTER J PH DDirectorSep 02Sale26.7657,6921,543,8388,500Sep 04 06:11 PM
Wells William McDowallDirectorSep 02Sale26.8830,000806,4000Sep 04 06:06 PM
Hacksell UliCEOAug 15Option Exercise6.8615,000102,90015,000Aug 15 05:44 PM
Hacksell UliCEOAug 15Sale22.8915,000343,371115,549Aug 15 05:44 PM